Request for Covid-19 Impact Assessment of this Report

Take Action
Healthcare

Computer-Aided Drug Discovery Market , By Type (Structure Based Drug Design (SBDD), Ligand-Based Drug Design (LBDD), Sequence-Based Approaches), By Therapeutic Area (Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diabetes), by End-User (Pharmaceutical Companies, Biotechnology Companies, Research Institute), Regional Analysis (North America, Europe, Asia-Pacific, LAMEA): Global Opportunity Analysis and Industry Forecast, 2019–2026

  • RES4072114
  • 170 Pages
  • April 2020
  • Healthcare
Download Sample    Get Discount   
 
The Computer-Aided Drug Discovery market size accounted for more than $1,540.4 million in 2018 and is estimated to witness a lucrative growth of over 15.5% during the forecast period.

Huge investments are being done by the key manufacturers in Computer-Aided Drug Discovery market for R&D activities to develop new drugs for various diseases such as cardiovascular diseases and oncology and is expected to drive the global computer-aided drug discovery market in the near future.

Based on Type, the Computer-Aided Drug Discovery market is categorized into Structure Based Drug Design (SBDD), Ligand-Based Drug Design (LBDD) and Sequence-Based Approaches. Ligand-based drug design segment is anticipated to drive the market growth in the recent years and is expected to reach $1,878.2 million growing at a CAGR of 15.2% during the projected time frame.

Computer-Aided Drug Discovery market based on therapeutic area is divided into oncology, neurology, cardiovascular disease, respiratory disease and diabetes among others. Oncology segment held the largest market value accounting for more than $355.8 million in 2018. However, cardiovascular disease segment is expected to boost the global Computer-Aided Drug Discovery market in the recent years and value for $917.2 million in 2018, boosting at a CAGR of 15.8% by 2026.

On the basis of end-user, the computer-Aided Drug Discovery market is segmented into pharmaceutical companies, biotechnology companies and research institutes. Research Institute is expected to lead the market in the year 2018 accounting for $602.3 million and is anticipated to continue its dominance during the forecast period. The research institutes segment is expected to account for $1,873.4 million by 2026 growing at CAGR of % during the forecasted period.

Depending on the region, the market is segregated into North America, Europe, Asia-Pacific and LAMEA. North America region accounted for $432.9 million in 2018 and is estimated to continue its dominance during the forecasted period. This growth is majorly due to the biotechnology and pharmaceutical industry, increased use of personalized medicine, a large number of ongoing drug development processes, and rising R&D expenditure by pharmaceutical and biotechnology companies.

The key market players in Computer -Aided Drug Discovery market include Albany Molecular Research Inc. (AMRI), BioDuro, Charles River, Schrödinger, Aragen Bioscience, Aris Pharmaceuticals, AstraZeneca, BOC Sciences, Evotec A.G., and Bayers AG among many others.

1.Research Methodology

1.1.Desk Research

1.2.Real time insights and validation

1.3.Forecast model

1.4.Assumptions and forecast parameters

1.4.1.Assumptions

1.4.2.Forecast parameters

1.5.Data sources

1.5.1.Primary

1.5.2.Secondary

2.Executive Summary

2.1.360° summary

2.2.Type trends

2.3.Therapeutic Area trends

2.4.End-user trends

3.Market overview

3.1.Market segmentation & definitions

3.2.key takeaways

3.2.1.Top investment pockets

3.2.2.Top winning strategies

3.3.Porter’s five forces analysis

3.3.1.Bargaining power of consumers

3.3.2.Bargaining power of suppliers

3.3.3.Threat of new entrants

3.3.4.Threat of substitutes

3.3.5.Competitive rivalry in the market

3.4.Market dynamics

3.4.1.Drivers

3.4.2.Restraints

3.4.3.Opportunities

3.5.Application landscape

3.6.Regulatory landscape

3.7.Patent landscape

3.8.Market value chain analysis

3.9.Strategic overview

4.Computer-Aided Drug Discovery Market, by Type

4.1.Structure Based Drug Design (SBDD)

4.1.1.Market size and forecast, by region, 2016-2026

4.1.2.Comparative market share analysis, 2018 &2026

4.2.Lignad-Based Drug Design (LBDD)

4.2.1.Market size and forecast, by region, 2016-2026

4.2.2.Comparative market share analysis, 2018 &2026

4.3.Sequence-Based Approaches

4.3.1.Market size and forecast, by region, 2016-2026

4.3.2.Comparative market share analysis, 2018 &2026

5.Computer-Aided Drug Discovery Market, by Therapeutic Area

5.1.Oncology

5.1.1.Market size and forecast, by region, 2016-2026

5.1.2.Comparative market share analysis, 2018 &2026

5.2.Neurology

5.2.1.Market size and forecast, by region, 2016-2026

5.2.2.Comparative market share analysis, 2018 &2026

5.3.Cardiovascular Disease

5.3.1.Market size and forecast, by region, 2016-2026

5.3.2.Comparative market share analysis, 2018 &2026

5.4.Respiratory Disease

5.4.1.Market size and forecast, by region, 2016-2026

5.4.2.Comparative market share analysis, 2018 &2026

5.5.Diabetes

5.5.1.Market size and forecast, by region, 2016-2026

5.5.2.Comparative market share analysis, 2018 &2026

5.6.Others

5.6.1.Market size and forecast, by region, 2016-2026

5.6.2.Comparative market share analysis, 2018 &2026

6.Computer-Aided Drug Discovery Market, by End-user

6.1.Pharmaceutical Companies

6.1.1.Market size and forecast, by region, 2016-2026

6.1.2.Comparative market share analysis, 2018 &2026

6.2.Biotechnology Companies

6.2.1.Market size and forecast, by region, 2016-2026

6.2.2.Comparative market share analysis, 2018 &2026

6.3.Research Institute

6.3.1.Market size and forecast, by region, 2016-2026

6.3.2.Comparative market share analysis, 2018 &2026

7.Computer-Aided Drug Discovery Market, by Region

7.1.North America

7.2.Market size and forecast, by Type, 2016-2026

7.3.Market size and forecast, by Application, 2016-2026

7.4.Market size and forecast, by country, 2016-2026

7.5.Comparative market share analysis, 2018 &2026

7.5.1.U.S.

7.5.1.1.Market size and forecast, by Type, 2016-2026

7.5.1.2.Market size and forecast, by Therapeutic Area, 2016-2026

7.5.1.3.Market size and forecast, by End-user, 2016-2026

7.5.1.4.Comparative market share analysis, 2018 &2026

7.5.2.Canada

7.5.2.1.Market size and forecast, by Type, 2016-2026

7.5.2.2.Market size and forecast, by Therapeutic Area, 2016-2026

7.5.2.3.Market size and forecast, by End-user, 2016-2026

7.5.2.4.Comparative market share analysis, 2018 &2026

7.5.3.Mexico

7.5.3.1.Market size and forecast, by Type, 2016-2026

7.5.3.2.Market size and forecast, by Therapeutic Area, 2016-2026

7.5.3.3.Market size and forecast, by End-user, 2016-2026

7.5.3.4.Comparative market share analysis, 2018 &2026

7.6.Europe

7.6.1.Market size and forecast, by Type, 2016-2026

7.6.2.Market size and forecast, by Application, 2016-2026

7.6.3.Market size and forecast, by country, 2016-2026

7.6.4.Comparative market share analysis, 2018 &2026

7.6.5.UK

7.6.5.1.Market size and forecast, by Type, 2016-2026

7.6.5.2.Market size and forecast, by Therapeutic Area, 2016-2026

7.6.5.3.Market size and forecast, by End-user, 2016-2026

7.6.5.4.Comparative market share analysis, 2018 &2026

7.6.6.Germany

7.6.6.1.Market size and forecast, by Type, 2016-2026

7.6.6.2.Market size and forecast, by Therapeutic Area, 2016-2026

7.6.6.3.Market size and forecast, by End-user, 2016-2026

7.6.6.4.Comparative market share analysis, 2018 &2026

7.6.7.France

7.6.7.1.Market size and forecast, by Type, 2016-2026

7.6.7.2.Market size and forecast, by Therapeutic Area, 2016-2026

7.6.7.3.Market size and forecast, by End-user, 2016-2026

7.6.7.4.Comparative market share analysis, 2018 &2026

7.6.8.Spain

7.6.8.1.Market size and forecast, by Type, 2016-2026

7.6.8.2.Market size and forecast, by Therapeutic Area, 2016-2026

7.6.8.3.Market size and forecast, by End-user, 2016-2026

7.6.8.4.Comparative market share analysis, 2018 &2026

7.6.9.Italy

7.6.9.1.Market size and forecast, by Type, 2016-2026

7.6.9.2.Market size and forecast, by Therapeutic Area, 2016-2026

7.6.9.3.Market size and forecast, by End-user, 2016-2026

7.6.9.4.Comparative market share analysis, 2018 &2026

7.6.10.Rest of Europe

7.6.10.1.Market size and forecast, by Type, 2016-2026

7.6.10.2.Market size and forecast, by Therapeutic Area, 2016-2026

7.6.10.3.Market size and forecast, by End-user, 2016-2026

7.6.10.4.Comparative market share analysis, 2018 &2026

7.7.Asia-Pacific

7.7.1.1.Market size and forecast, by Type, 2016-2026

7.7.1.2.Market size and forecast, by Therapeutic Area, 2016-2026

7.7.2.Market size and forecast, by End-user, 2016-2026

7.7.3.Market size and forecast, by country, 2016-2026

7.7.4.Comparative market share analysis, 2018 &2026

7.7.5.China

7.7.5.1.Market size and forecast, by Type, 2016-2026

7.7.5.2.Market size and forecast, by Therapeutic Area, 2016-2026

7.7.5.3.Market size and forecast, by End-user, 2016-2026

7.7.5.4.Comparative market share analysis, 2018 &2026

7.7.6.Japan

7.7.6.1.Market size and forecast, by Type, 2016-2026

7.7.6.2.Market size and forecast, by Therapeutic Area, 2016-2026

7.7.6.3.Market size and forecast, by End-user, 2016-2026

7.7.6.4.Comparative market share analysis, 2018 &2026

7.7.7.India

7.7.7.1.Market size and forecast, by Type, 2016-2026

7.7.7.2.Market size and forecast, by Therapeutic Area, 2016-2026

7.7.7.3.Market size and forecast, by End-user, 2016-2026

7.7.7.4.Comparative market share analysis, 2018 &2026

7.7.8.Australia

7.7.8.1.Market size and forecast, by Type, 2016-2026

7.7.8.2.Market size and forecast, by Therapeutic Area, 2016-2026

7.7.8.3.Market size and forecast, by End-user, 2016-2026

7.7.8.4.Comparative market share analysis, 2018 &2026

7.7.9.South Korea

7.7.9.1.Market size and forecast, by Type, 2016-2026

7.7.9.2.Market size and forecast, by Therapeutic Area, 2016-2026

7.7.9.3.Market size and forecast, by End-user, 2016-2026

7.7.9.4.Comparative market share analysis, 2018 &2026

7.7.10.Rest of Asia-Pacific

7.7.10.1.Market size and forecast, by Type, 2016-2026

7.7.10.2.Market size and forecast, by Therapeutic Area, 2016-2026

7.7.10.3.Market size and forecast, by End-user, 2016-2026

7.7.10.4.Comparative market share analysis, 2018 &2026

7.8.LAMEA

7.8.1.1.Market size and forecast, by Type, 2016-2026

7.8.1.2.Market size and forecast, by Therapeutic Area, 2016-2026

7.8.2.Market size and forecast, by End-user, 2016-2026

7.8.3.Market size and forecast, by country, 2016-2026

7.8.4.Comparative market share analysis, 2018 &2026

7.8.5.Latin America

7.8.5.1.Market size and forecast, by Type, 2016-2026

7.8.5.2.Market size and forecast, by Therapeutic Area, 2016-2026

7.8.5.3.Market size and forecast, by End-user, 2016-2026

7.8.5.4.Comparative market share analysis, 2018 &2026

7.8.6.Middle East

7.8.6.1.Market size and forecast, by Type, 2016-2026

7.8.6.2.Market size and forecast, by Therapeutic Area, 2016-2026

7.8.6.3.Market size and forecast, by End-user, 2016-2026

7.8.6.4.Comparative market share analysis, 2018 &2026

7.8.7.Africa

7.8.7.1.Market size and forecast, by Type, 2016-2026

7.8.7.2.Market size and forecast, by Therapeutic Area, 2016-2026

7.8.7.3.Market size and forecast, by End-user, 2016-2026

7.8.7.4.Comparative market share analysis, 2018 &2026

1.Company profiles

1.1.InfineonTechnologies

1.1.1.Business overview

1.1.2.Financial performance

1.1.3.Type portfolio

1.1.4.Recent strategic moves & developments

1.1.5.SWOT analysis

1.2.Mitsubishi

1.2.1.Business overview

1.2.2.Financial performance

1.2.3.Type portfolio

1.2.4.Recent strategic moves & developments

1.2.5.SWOT analysis

1.3. Fuji Electric

1.3.1.Business overview

1.3.2.Financial performance

1.3.3.Type portfolio

1.3.4.Recent strategic moves & developments

1.3.5.SWOT analysis

1.4.Semikron

1.4.1.Business overview

1.4.2.Financial performance

1.4.3.Type portfolio

1.4.4.Recent strategic moves & developments

1.4.5.SWOT analysis

1.5.ON Semiconductors

1.5.1.Business overview

1.5.2.Financial performance

1.5.3.Type portfolio

1.5.4.Recent strategic moves & developments

1.5.5.SWOT analysis

1.6. FairchildSemiconductor

1.6.1.Business overview

1.6.2.Financial performance

1.6.3.Type portfolio

1.6.4.Recent strategic moves & developments

1.6.5.SWOT analysis

1.7.Texas Instruments Incorporated

1.7.1.Business overview

1.7.2.Financial performance

1.7.3.Type portfolio

1.7.4.Recent strategic moves & developments

1.7.5.SWOT analysis

1.8.STMicroelectronics

1.8.1.Business overview

1.8.2.Financial performance

1.8.3.Type portfolio

1.8.4.Recent strategic moves & developments

1.8.5.SWOT analysis

1.9.IXYS

1.9.1.Business overview

1.9.2.Financial performance

1.9.3.Type portfolio

1.9.4.Recent strategic moves & developments

1.9.5.SWOT analysis

1.10.Toshiba

1.10.1.Business overview

1.10.2.Financial performance

1.10.3.Type portfolio

1.10.4.Recent strategic moves & developments

1.10.5.SWOT analysis

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Digital Pathology Market by Product (Whole Slide Imaging, Image Analysis Informatics, Information Management System Storage & Communication, Digital IVD Devices, and Others [Telepathology]), Type (Automated Hematology Analyzers & Blood Cell Counters, Chromosome Analyzers, FISH Enumeration Systems, Urine Sediment Analyzers, Immunohistochemistry Image Analysis Applications, Digital Cytopathology, Digital PCR, Signet Cell Detection, and Digital Holographic Microscopy), and End User (Educational, Clinical, and Pharma & Biotech Companies) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...

  • Publish Date: February 26, 2018
  • $5370
View Details
Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
View Details
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370
View Details
 
View More
 

Client Testimonials

2024 © Copyright Big Market Research